About

John A. Taylor III, M.D., M.C.T.S.

Member, Clinical Advisory Board

Dr. Taylor is a board-certified urologist and nationally recognized expert on bladder cancer. His work has been recognized by multiple peer-reviewed publications and several U.S. provisional/full patents. He joined the University of Kansas Medical Center in 2016 and serves as a Professor, Director of Basic Urologic Research and Co-Leader of the D3ET Program. He will serve as Principal Investigator for clinical trials in muscle invasive and non-muscle invasive bladder cancer patients. Dr. Taylor also founded and serves as President and Director of the Leo & Anne Albert Institute for Bladder Cancer Care and Research. He earned his medical degree at Columbia University’s College of Physicians & Surgeons, where he also completed his internship and residency in general surgery and urology. He served three years on active duty at Walter Reed Army Medical Center and was Director of Medical Education for Urology and Assistant Professor at USUHS. He then took a faculty position at the University of Connecticut Health Center, and while there completed a Master’s in Clinical and Translation Science. Dr. Taylor runs a translational research laboratory focused on identification and development of novel compounds for the treatment of bladder cancer. He participates regularly on national and international committees to develop standards for bladder cancer care and has served on the AUA’s research council, the NIH/NCI Bladder Cancer Task Force for Clinical Trial Development and as an ad hoc member of the FDA’s Oncologic Drug Advisory Committee.